Bli medlem
Bli medlem

Du är här


aap: Market launch of polyaxial LOQTEQ® VA ankle system

VA ankle system.
Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely
responsible for the content of this announcement.
* Polyaxial system enables flexible treatment of ankle fractures

Implantate AG ("aap"
) announces the market launch of the polyaxial LOQTEQ® VA Distal Tibia and
Fibula Plates 2.7/3.5. The system enables the flexible treatment of ankle
fractures, thereby addressing one of the most frequent fractures of
load-bearing joints. The LOQTEQ® VA Distal Tibia and Fibula Plates 2.7/3.5
belong to the LOQTEQ® VA (VA = Variable Angle) product family, which are
polyaxial implants that facilitate inserting angle-stable screws at different
angles. Polyaxial implants are required for treating areas such as the ankle
that in surgery require both angle stability and flexibility in the insertion
of screws.

Ankle fractures are among the most frequent fractures that receive trauma surgery treatment. To meet patients' growing demands, a fast, mobilization-stable treatment with a permanent retention of the repositioning result is required. The special combination of anatomically preformed and angle-stable plates in conjunction with freely selectable screw angles and user-friendly instruments fulfils all the requirements of modern fracture management.
The LOQTEQ® VA ankle system 2.7/3.5 consists of distal plates for the treatment of medial and anterolateral fractures of the tibia and plates for treating lateral fractures of the fibula. Variable, angle-stable round holes in the part of the plate that is close to the joint have been added to the monoaxial version of the LOQTEQ® ankle system that is already successful on the market and the profile of the tibia plates has been further optimised. The LOQTEQ® Fibula Plate 3.5 was additionally converted for 2.7 mm diameter screws in the distal part in order to fix small fracture fragments and minimise protrusion of screw heads in the event of deviations from the pre-set angle. The anatomical fit of the system as well as the low profile, the rounded edges and the smooth surfaces reduce the risk of soft tissue irritation.
will shortly be launching further polyaxial variants of different LOQTEQ® products for various anatomical areas in the market.
Implantate AG

Implantate AG is a globally operating medical device company headquartered in
Berlin, Germany. The company develops, manufactures and markets trauma
products for orthopaedics. The IP protected portfolio includes besides the
innovative anatomical plating system LOQTEQ® and trauma complementary
biomaterials a wide range of cannulated screws as well as standard plates and
screws. Furthermore,aap
Implantate AG has an innovation pipeline with promising development projects
as the antibacterial silver coating technology and magnesium based implants.
These technologies address critical problems in surgery that haven't yet been
resolved adequately. In German-speaking Europeaap
Implantate AG directly sells its products to hospitals, buying syndicates and
hospital groups while it uses a broad network of distributors in more than 25
countries at the international level.aap
Implantate AG's stock is listed in the Prime Standard segment of Frankfurt
Stock Exchange (XETRA: AAQ.DE). For more information, please visit, or download the Company's investor relations app from the Apple's
App Store or Google Play.

Forward-looking statement

This release may contain forward-looking statements based on current
experience, estimates and projections of the management board and currently
available information. They are not guarantees of future performance. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. Many
factors could cause the actual results, performance or achievements of aap to
be materially different from those that may be expressed or implied by such
statements. These factors include those discussed inaap
's public reports. Forward-looking statements therefore speak only as of the
date they are made.aap
does not assume any obligation to update the forward-looking statements
contained in this release or to conform them to future events or

For inquiries please contact:aap
Implantate AG, Fabian Franke, Investor Relations, Lorenzweg 5, 12099 Berlin,

Tel.: +49 30 7501 9-134, fax: +49 30 7501 9-290, e-mail: f.franke@aap


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: aap Implantate AG via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.